SPATA19 Antikörper (N-Term)

Produktnummer ABIN1450102

Produktdetails anti-SPATA19 Antikörper

Target: SPATA19 (Spermatogenesis Associated 19 (SPATA19))

Bindungsspezifität: N-Term

Reaktivität: Human, Maus, Ratte

Wirt: Huhn

Klonalität: Polyklonal

Konjugat: Dieser SPATA19 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Aufreinigung: Affinity chromatography purified via peptide column

Immunogen: SPATA19 antibody was raised against an 17 amino acid synthetic peptide near the amino terminus of human SPATA19.

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store the antibody (in aliquots) at -20 °C.

Details zu SPATA19

Target: SPATA19 (Spermatogenesis Associated 19 (SPATA19))

Andere Bezeichnung: SPATA19 / SPERGEN1 (SPATA19 Produkte)

Hintergrund: SPATA19, also known as SPERGEN1, was initially identified as a testis-specific protein that localizes to the surface of mitochondria in the middle piece of mature spermatozoa. Recent experiments have shown that elevated levels of SPATA19 have been found in basal cell carcinomas and prostate cancers, suggesting that SPATA19 may serve as a putative cancer biomarker and a target for cancer immunotherapy.Synonyms: FLJ25851, SPAS1, Spergen-1, Spermatogenesis-associated protein 19, Spermatogenic cell-specific gene 1 protein

Gen-ID: 219938